학술논문

Corrigendum to ‘Chemotherapy and PARP inhibitors in heavily pretreated BRCA1/2 mutation ovarian cancer (BMOC) patients’ [Gynecologic Oncology 152 (2019) 270-277]
Document Type
Erratum
Source
In Gynecologic Oncology January 2020 156(1):262-262
Subject
Language
ISSN
0090-8258